Tajuk
Belantamab Mafodotin For Relapsed/Refractory Multiple Myeloma (RRMM)
Tahun
2020-003-S
Lampiran-lampiran
TS BELANTAMAB MAFODOTIN FOR RELAPSED_REFRACTORY MULTIPLE MYELOMA (RRMM) 003_2020.pdf